PATENT CLAIM ANALYSIS

Application Number: 15906353
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-06
Patent Classification: ["514", "001700"]

Abstract:
The present invention provides a method to treat asthma and airway allergy by administering the dipeptide cyclo tyrosine-valine or a related cyclodipeptide compound to a subject in need thereof. Cyclo tyrosine-valine or the related cyclodipeptide compound reduces Th2 cell activation, airway hyperresponsiveness, accumulation of immune cells in bronchoalveolar fluid, and allergen-specific antibody production in an animal or human subject. The compound can therefore be used to treat asthma and airway allergy.

Claim (Index 3):
The method of  claim 1 , wherein the effective amount of the cyclo tyrosine-valine or the related cyclodipeptide compound is 0.003 mg/kg of body weight per day.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.54
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13258804', '14186069', '11705829', '12492494', '15675074']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7841740650727487
- 35 USC 102 Novelty (BERT): 0.5146457798561509
- Combined Prediction Score: 0.757221236551089
- Mean Citation Score: 262.54670600000003
- Max Citation Score: 272.93274
- Similarity Product: 174.8231344739771

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test